posid
Brand Name: POSID
Composition: Etoposide Capsules IP 50 mg
Marketed By: ONCOCARE (A Division of Cadila Pharmaceuticals Ltd.)
Product Description
Medical Info
POSID is a prescription oncology medication containing Etoposide (50 mg) in capsule form. It belongs to a class of chemotherapy drugs known as topoisomerase inhibitors. The medication works by binding to and blocking the topoisomerase II enzyme, which prevents cancer cells from repairing their DNA strands and ultimately forces them to stop dividing and die. POSID is widely used in combination with other chemotherapy agents to treat various malignancies, including refractory testicular tumors and small cell lung cancer. Given its narrow therapeutic index and potential to cause significant bone marrow suppression, treatment must be closely monitored by a qualified specialist.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
